Updates
Updated NC Statewide Overdose Surveillance Reports for October 2021
The Injury and Violence Prevention Branch of the Division of Public Health recently updated provisional data on suspected opioid overdose EMS encounters and ED visits for opioid-related overdose and unintentional med/drug with potential for abuse overdose for October...
Fatal Opioid Overdoses Four Times More Likely Immediately After Discharge
A new study shows just how risky the period after hospital discharge can be for people who use illicit opioids such as heroin. Fatal opioid overdoses are four times more likely in the first two days after hospital discharge than at other times. The research, published...
Methamphetamine Deaths Skyrocket, Hitting Black and Native Americans Especially Hard
A study in the journal JAMA Psychiatry suggests methamphetamine use is surging as a major cause of high-risk addiction and overdose death in the U.S. From 2015 to 2019, the number of deaths linked to methamphetamine use rose from 5,526 a year to more than 15,000 a...
COVID Brings Increase in Cannabis Use Among Pregnant Women
According to data published in JAMA last month, prenatal cannabis use increased by 25% during the pandemic over prenatal cannabis use during the 15 months before the pandemic. The study involved over 100,000 pregnancies in Northern California. Prenatal cannabis use is...
AMA Calls on Lawmakers to “Act Now” Amid Overdose Statistic
According to a new report from the American Medical Association (AMA), physicians have prescribed 44 percent less opioids over the past decade, yet fatal and nonfatal drug overdoses have continued to soar. AMA’s report documented a 44.4 percent decrease in opioid...
Thousands of Unknown Chemicals Found in E-Cigarettes
Researchers at Johns Hopkins University have found vaping aerosols contain thousands of unknown chemicals and substances not disclosed by manufacturers, including industrial chemicals and caffeine. The results, recently published in the journal Chemical Research in...
Target Audience
This program is recommended for physicians, nurses, physician assistants, pharmacists, nurse practitioners, medical assistants, care managers, care coordinators, and mental health professionals (including substance abuse counselors, social workers, psychologists, school counselors, and marriage and family therapists), and other professionals interested in this subject.
Objectives
- Recognize the epidemiology of stimulant use disorder and current data trends on use of stimulants
- Define stimulant use disorder and apply theories of pathophysiology
- Identify signs and symptoms of a patient with stimulant use disorder
- Describe behavioral therapy methods and pharmacotherapy options for stimulant use disorder
- Interpret stigma, bias, health equity and disparities among people who use drugs
- Identify harm reduction strategies for people who use stimulants
Target Audience
This program is recommended for physicians, nurses, physician assistants, pharmacists, nurse practitioners, medical assistants, care managers, care coordinators, and mental health professionals (including substance abuse counselors, social workers, psychologists, school counselors, and marriage and family therapists), and other professionals interested in this subject.
Objectives
- Recognize the epidemiology of stimulant use disorder and current data trends on use of stimulants
- Define stimulant use disorder and apply theories of pathophysiology
- Identify signs and symptoms of a patient with stimulant use disorder
- Describe behavioral therapy methods and pharmacotherapy options for stimulant use disorder
- Interpret stigma, bias, health equity and disparities among people who use drugs
- Identify harm reduction strategies for people who use stimulants
Target Audience
This program is recommended for physicians, nurses, physician assistants, pharmacists, nurse practitioners, medical assistants, care managers, care coordinators, and mental health professionals (including substance abuse counselors, social workers, psychologists, school counselors, and marriage and family therapists), and other professionals interested in this subject.
Objectives
- Recognize the epidemiology of stimulant use disorder and current data trends on use of stimulants
- Define stimulant use disorder and apply theories of pathophysiology
- Identify signs and symptoms of a patient with stimulant use disorder
- Describe behavioral therapy methods and pharmacotherapy options for stimulant use disorder
- Interpret stigma, bias, health equity and disparities among people who use drugs
- Identify harm reduction strategies for people who use stimulants
Target Audience
This program is recommended for physicians, nurses, physician assistants, pharmacists, nurse practitioners, medical assistants, care managers, care coordinators, and mental health professionals (including substance abuse counselors, social workers, psychologists, school counselors, and marriage and family therapists), and other professionals interested in this subject.
Objectives
- Recognize the epidemiology of stimulant use disorder and current data trends on use of stimulants
- Define stimulant use disorder and apply theories of pathophysiology
- Identify signs and symptoms of a patient with stimulant use disorder
- Describe behavioral therapy methods and pharmacotherapy options for stimulant use disorder
- Interpret stigma, bias, health equity and disparities among people who use drugs
- Identify harm reduction strategies for people who use stimulants
Target Audience
This program is recommended for physicians, nurses, physician assistants, pharmacists, nurse practitioners, medical assistants, care managers, care coordinators, and mental health professionals (including substance abuse counselors, social workers, psychologists, school counselors, and marriage and family therapists), and other professionals interested in this subject.
Objectives
- Recognize the epidemiology of stimulant use disorder and current data trends on use of stimulants
- Define stimulant use disorder and apply theories of pathophysiology
- Identify signs and symptoms of a patient with stimulant use disorder
- Describe behavioral therapy methods and pharmacotherapy options for stimulant use disorder
- Interpret stigma, bias, health equity and disparities among people who use drugs
- Identify harm reduction strategies for people who use stimulants
Learn more about our conferences and educational opportunities
Addiction Medicine Spring and Fall Conferences provide up-to-date substance use related education, applicable across general medical as well as addiction specialty practices.